The Pandemic Changed Their Lives – And Brought Them Closer Together

A patch of dirt in the northwest corner of their back yard, bounded by a chain link fence, a stone wall and a garage that houses feral cats, has become a happy place for Gladis Castro, 57, and her daughter Carla, 27. The Danbury mother and daughter have found purpose and meaning, and built a strong relationship, in a simple garden that has connected them with nature, given them food and provided a diversion from the COVID-19 pandemic. Just being outdoors has become increasingly important to them in caring for their long-term respiratory effects from the virus. Inhaling the early-morning air while working in her garden often reminds Gladis Castro of Santa Isabel, her village in the Andes mountains of Ecuador. After a morning summer walk the two made smoothies with freshly picked red raspberries from their garden.

After Trials With Yale Researchers, FDA-Approved Treatment To Delay Type 1 Diabetes Brings Hope

The Food and Drug Administration’s recent approval of the first treatment that would delay the onset of type 1 diabetes ignited joy and hope among families impacted by the chronic, incurable disease. A clinical study found immunotherapy treatment with the drug teplizumab postponed the onset of type 1 diabetes (T1D) among at-risk children and adults for an average of two years, and for one patient, 11 years and counting. “Half the people in the study are way beyond two years,” says Yale University’s Dr. Kevan Herold, who has been working on a cure for T1D for 30 years. People with T1D have to manage the disease 24/7 or risk dangerously low or high blood sugar levels and long-term complications, said Herold, the clinical trial’s principal investigator. Before participating in a clinical trial at age 9, Claire Wirt, now 16, had antibodies that put her at risk of developing T1D within two years.

Mental Health Providers Say DSS Has Imposed Restrictive Requirements On Transgender Patients

A coalition of mental health providers who treat transgender people in Connecticut has complained for months that the state Department of Social Services (DSS) has imposed what they call unnecessary and overly restrictive requirements on patients seeking gender-affirming surgery. The changes affect low-income patients on the state’s Husky health insurance. Before covering genital surgery to treat gender dysphoria – the psychological distress that can result from an incongruence between one’s sex assigned at birth and their gender identity – DSS now requires proof that the person has lived for at least a year in the new gender and has come out to family and friends. DSS accepts a legal name change as proof. In March, DSS imposed a blanket denial of gender-affirming surgery for anyone under 18 and began requiring two letters from mental health professionals assessing transgender patients before some surgeries would be covered, Alexandra Solomon, a clinical social worker with a therapy practice in Glastonbury and one of the leaders of the coalition, said.

The Healing Powers Of The Great Outdoors

When Herb Virgo spends time on the trails in Hartford’s Keney Park, he feels different. There’s a “heightened sense of wellbeing, a feeling of connectedness,” he said of spending time outside at the nearly 693-acre park in Hartford’s North End. “There are portions of the park that you can visit that completely make you feel like you’re in another place, in another world. Not only in another city, but in a completely different ecosystem.” Virgo is the founder and executive director of Keney Park Sustainability Project and is dedicated to helping others have similar experiences through the project’s Urban Ecology Wellness Center at Keney Park initiative.

After Stillbirth, Undocumented Woman Organizes Partnership To Help Others Find Better Care

When Laura Garcia was pregnant with her third child, a boy she named Matias, she had symptoms that made her uneasy. Her nails turned purple, her feet were swollen and she was vomiting. Undocumented and uninsured, she sought care in a community clinic. “They told me it’s normal,” said Garcia of Norwalk. But one day in her 39th week of pregnancy, as she returned home from work, she could no longer feel the baby moving.

The Unknown Puts Offspring At Risk Of Sickle Cell Disease

Most Connecticut residents who carry a trait for sickle cell disease don’t know it, resulting in thousands of people unwittingly risking having a child born with the debilitating illness, according to sickle cell disease specialists. The reasons for this vary: there’s a lack of knowledge about results of newborn testing for the trait, parents don’t always convey test results to their children, gaps in state record keeping, and state records that identify people with the disease or trait only go back to 2012. Also, doctors typically only test for the trait when a patient requests it. And people often don’t know they can have the trait even when sickle cell disease isn’t in their family. Dr. Biree Andemariam, director of the New England Sickle Cell Institute at UConn Health, said physicians should include trait testing in routine exams. “It should be standard care,” she said.

Race, Economics, Environment Continue To Drive State’s Asthma Disparities

Kamyle Dunn used to sleep with her hand resting on her mother’s chest so she could feel it expand and contract and know that her mom hadn’t stopped breathing during the night. Dunn’s mother, Maria Cotto, has long had severe asthma. Dunn inherited the condition, though she has mostly grown out of it as an adult. Now, Dunn’s 12-year-old son also has severe asthma. “People kind of shrug it off as not that big of a deal,” said Dunn, who lives with her family in East Harford. “But I see what it’s done to my mother, and I see what it’s doing to my son, and what it has done to me.”

In Connecticut, 10.6% of children and 10.5% of adults have asthma, according to state data from 2019.  According to DataHaven’s 2021 Community Wellbeing survey, 12% of adults have asthma.

Rise In Food Insecurity Drives Innovative Strategies

An abundance of healthy selections. Clearly marked nutrition labeling. The ability to pre-order. Fresh produce and meat. The 364,040 people in Connecticut who face hunger—one in every 10 residents—are increasingly likely to find these and other grocery store-like features at their local food pantries.

Will New School Year Test New Haven Board’s Policy Aimed At Protecting Transgender And Nonconforming Students?

One by one, speakers lined up at a New Haven Board of Education meeting last fall to support a policy ensuring “the safety, comfort, and healthy development” of LGBTQ youths in school. Parents, teachers, advocates and students came forward, most with an anecdote and a plea: to protect children in New Haven schools who are bullied, unable to find safe bathrooms, and are referred to by the wrong pronouns—all because of their gender identity. Following the testimony, the school board unanimously approved the Transgender and Gender Non-Conforming Youth policy. Among other things, it grants students the right to change their name and gender identity on school records without parental permission; the right to be called by their preferred name and pronoun in school; the right to keep this information private without school staff telling parents or peers; access to gender-neutral bathrooms and more. By the end of the school year, what changes had the policy affected?

Clinical Trials With Immunotherapy Drugs Are Source Of Hope And Challenges In Treating Aggressive Breast Cancer

Joshalyn Mills of Branford and Nancy Witz of Kensington had the best possible results after being treated in clinical trials with immunotherapy drugs for aggressive breast cancer: Their tumors were eliminated. But while there are dramatic successes with immunotherapy drugs, there are also many failures, and researchers are trying to find out why in hopes of expanding the drugs’ effectiveness. Cutting-edge immunotherapy drugs use a person’s own immune system to fight disease. The Food and Drug Administration (FDA) first approved the drugs in 2011 for cancer treatment. Success has occurred in about 15% to 20% of patients with cancers such as melanoma, lung, kidney and bladder, according to a report by Johns Hopkins School of Medicine.